3Metzgar D, Zampolli A. The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identifi cation marker [ J ]. Virulence, 2011,2 ( 5 ) : 402-412.
4Col-Araz N, Pehlivan S, Baspinar O, et al. Role of cytokine gene (IFN-,, TNF-a, TGF-13I, IL-6, and IL-10) polymorphisms in pathogenesis of acute rheumatic fever in Turkish children [Jl. Eur J Pediatr,2012,17(3) : 100-105.
5Mohamed AA, Rashed LA, Shaker SM, et ol. Association of tumor necrosis factor-alpha polymorphisms with susceptibility and clinical outcomes of rheumatic heart disease [ J 1- Saudi Medical J,2010,31 (6) :644-649.
6Boldt AB, Goeldner I, Messias-Reason IJ. Relevance of the lectin pathway of complement in rheumatic diseases [ J ]. Adv Clin Chem,2012,56:105-153.
7Azevedo PM, Bauer R, Caparbo Ved F, et al. Interleukin-1 receptor antagonist gene (tL1RN) polymorphism possibly associa- ted to severity of rheumatic carditis in a Brazilian cohort [J]. Cytokine, 2010,49(1 ) : 109-113.
8Scalzi V, Hadi HA, Alessandri C, et ol. Anti-endothelia| cell antibodies in rheumatic heart disease [J]. Clin Exp Immunol, 2010,161 (3) : 570-575.
9Toor D, Leal K, Kumar R, et al. Association of HLA-DRBI*14 with rheumatic heart disease patients from Chandigarh ,North India [J. Biomarkers,2012,17(2) : 160-165.
10Ozdemir O, Islk S, Abaci A, et al. Silent enemy in acute rheumatic fever: subclinical carditis [J]. Turk Kardiyol Dern AM, 2011,39(1) :41-46.
